DK1745052T3 - HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelser - Google Patents
HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelserInfo
- Publication number
- DK1745052T3 DK1745052T3 DK05738619T DK05738619T DK1745052T3 DK 1745052 T3 DK1745052 T3 DK 1745052T3 DK 05738619 T DK05738619 T DK 05738619T DK 05738619 T DK05738619 T DK 05738619T DK 1745052 T3 DK1745052 T3 DK 1745052T3
- Authority
- DK
- Denmark
- Prior art keywords
- intergrase
- hiv
- inhibitors
- pyrimidinone compounds
- cyclic
- Prior art date
Links
- -1 cyclic pyrimidinone compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/527—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57034804P | 2004-05-12 | 2004-05-12 | |
| PCT/US2005/013911 WO2005113562A1 (en) | 2004-05-12 | 2005-04-22 | Hiv integrase inhibitors: cyclic pyrimidinone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1745052T3 true DK1745052T3 (da) | 2009-01-05 |
Family
ID=34967012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05738619T DK1745052T3 (da) | 2004-05-12 | 2005-04-22 | HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelser |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US7273859B2 (da) |
| EP (1) | EP1745052B9 (da) |
| JP (1) | JP2007537251A (da) |
| KR (1) | KR20070014173A (da) |
| CN (1) | CN1984917A (da) |
| AR (1) | AR049498A1 (da) |
| AT (1) | ATE405570T1 (da) |
| AU (1) | AU2005245789A1 (da) |
| BR (1) | BRPI0511078A (da) |
| CA (1) | CA2566755A1 (da) |
| DE (1) | DE602005009172D1 (da) |
| DK (1) | DK1745052T3 (da) |
| ES (1) | ES2310823T3 (da) |
| HR (1) | HRP20080531T3 (da) |
| IL (1) | IL179161A0 (da) |
| MX (1) | MXPA06013023A (da) |
| NO (1) | NO20065443L (da) |
| NZ (1) | NZ550698A (da) |
| PE (1) | PE20060238A1 (da) |
| PL (1) | PL1745052T3 (da) |
| PT (1) | PT1745052E (da) |
| RU (1) | RU2006143683A (da) |
| SI (1) | SI1745052T1 (da) |
| TW (1) | TW200540173A (da) |
| WO (1) | WO2005113562A1 (da) |
| ZA (1) | ZA200609181B (da) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115601B2 (en) | 2004-05-18 | 2006-10-03 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7981879B2 (en) * | 2005-03-31 | 2011-07-19 | Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. | HIV integrase inhibitors |
| US7494984B2 (en) * | 2005-08-31 | 2009-02-24 | Bristol-Myers Squibb Company | Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors |
| WO2007058646A1 (en) * | 2005-11-15 | 2007-05-24 | Bristol-Myers Squibb Company | Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| WO2007059125A2 (en) * | 2005-11-15 | 2007-05-24 | Bristol-Myers Squibb Company | Hiv integrase inhibitors |
| US7902182B2 (en) * | 2005-11-16 | 2011-03-08 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| WO2007064502A1 (en) * | 2005-12-01 | 2007-06-07 | Bristol-Myers Squibb Company | Forms of n-[(4-fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide |
| US7897593B2 (en) * | 2006-05-30 | 2011-03-01 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7893055B2 (en) * | 2006-06-28 | 2011-02-22 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US7763630B2 (en) * | 2007-06-06 | 2010-07-27 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US8129398B2 (en) * | 2008-03-19 | 2012-03-06 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| EP2212324B1 (en) | 2008-07-02 | 2014-03-26 | Avexa Limited | Compounds having antiviral properties |
| EP2291377B1 (en) * | 2008-07-02 | 2015-02-18 | Avexa Limited | Imidazopyrimidinones and uses thereof |
| WO2010042391A2 (en) * | 2008-10-06 | 2010-04-15 | Merck Sharp & Dohme Corp. | Hiv integrase inhibitors |
| AU2010208470A1 (en) * | 2009-01-28 | 2011-08-04 | Merck Sharp & Dohme Corp. | Bridged compounds as HIV integrase inhibitors |
| US8143244B2 (en) * | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| EP2470014A4 (en) * | 2009-08-26 | 2013-01-16 | Merck Sharp & Dohme | HIV integrase inhibitors |
| US8383639B2 (en) | 2009-10-15 | 2013-02-26 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| WO2011075747A1 (en) * | 2009-12-18 | 2011-06-23 | Glaxosmithkline Llc | Therapeutic compounds |
| US9328075B2 (en) * | 2011-05-05 | 2016-05-03 | St. Jude Children's Research Hospital | Pyrimidinone compounds and methods for treating influenza |
| US10699038B2 (en) | 2012-03-30 | 2020-06-30 | Litmus Blue Technology LLC | Configurable representation of domain models |
| WO2014008636A1 (en) * | 2012-07-11 | 2014-01-16 | Merck Sharp & Dohme Corp. | Macrocyclic compounds as hiv integrase inhibitors |
| EP2931730B1 (en) | 2012-12-17 | 2019-08-07 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as hiv integrase inhibitors |
| DK3067358T3 (da) | 2012-12-21 | 2019-11-04 | Gilead Sciences Inc | Polycykliske carbamoylpyridon-forbindelser og deres farmaceutiske anvendelse |
| EP2940019B1 (en) | 2012-12-27 | 2018-03-28 | Japan Tobacco Inc. | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR |
| WO2014172188A2 (en) | 2013-04-16 | 2014-10-23 | Merck Sharp & Dohme Corp. | 4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors |
| WO2014183532A1 (en) | 2013-05-17 | 2014-11-20 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| WO2014200880A1 (en) | 2013-06-13 | 2014-12-18 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| PT3019503T (pt) | 2013-07-12 | 2017-11-27 | Gilead Sciences Inc | Compostos carbamoílpiridona- policíclicos e seu uso para o tratamento de infecções por hiv |
| NO2865735T3 (da) | 2013-07-12 | 2018-07-21 | ||
| PE20160501A1 (es) | 2013-09-27 | 2016-05-14 | Merck Sharp & Dohme | Derivados de quinolizina sustituidos utiles como inhibidores de integrasa del vih |
| EP3087060B1 (en) | 2013-12-23 | 2020-05-13 | Merck Sharp & Dohme Corp. | Pyrimidone carboxamide compounds as pde2 inhibitors |
| TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
| TWI744723B (zh) | 2014-06-20 | 2021-11-01 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
| NO2717902T3 (da) | 2014-06-20 | 2018-06-23 | ||
| TWI738321B (zh) | 2014-12-23 | 2021-09-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
| WO2016145614A1 (en) | 2015-03-17 | 2016-09-22 | Merck Sharp & Dohme Corp. | Triazolyl pyrimidinone compounds as pde2 inhibitors |
| US10287269B2 (en) | 2015-03-26 | 2019-05-14 | Merck Sharp & Dohme Corp. | Pyrazolyl pyrimidinone compounds as PDE2 inhibitors |
| KR20190057158A (ko) | 2015-04-02 | 2019-05-27 | 길리애드 사이언시즈, 인코포레이티드 | 폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도 |
| WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
| WO2016209749A1 (en) | 2015-06-25 | 2016-12-29 | Merck Sharp & Dohme Corp. | Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors |
| WO2017000277A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
| WO2017087257A1 (en) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
| US10544155B2 (en) | 2015-12-15 | 2020-01-28 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors |
| WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| CN110062627A (zh) | 2016-12-02 | 2019-07-26 | 默沙东公司 | 可用作hiv整合酶抑制剂的三环杂环化合物 |
| JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| EP3573984A4 (en) | 2017-01-26 | 2020-07-29 | Merck Sharp & Dohme Corp. | USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9201803D0 (en) * | 1992-01-28 | 1992-03-11 | Smithkline Beecham Corp | Methods |
| DE60218511T2 (de) | 2001-10-26 | 2007-10-25 | Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase |
| EA007060B1 (ru) | 2001-10-26 | 2006-06-30 | Иституто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа | N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы |
| WO2004002406A2 (en) | 2002-06-26 | 2004-01-08 | Bristol-Myers Squibb Company | Bicyclic pyrimidinones as coagulation cascade inhibitors |
| BR0317749A (pt) | 2002-12-27 | 2005-11-22 | Angeletti P Ist Richerche Bio | Composto, composição farmacêutica, e, uso de um composto |
| AR046938A1 (es) | 2003-12-12 | 2006-01-04 | Merck & Co Inc | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
| TW200526635A (en) | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| EP1711476A2 (en) | 2004-01-12 | 2006-10-18 | Gilead Sciences, Inc. | Pyrimidyl phosphonate antiviral compounds and methods of use |
| US7173022B2 (en) * | 2004-05-28 | 2007-02-06 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
| US7981879B2 (en) * | 2005-03-31 | 2011-07-19 | Instituto di Ricerchi di Biologia Molecolare P. Angeletti S.p.A. | HIV integrase inhibitors |
| DK3187225T3 (da) * | 2005-04-28 | 2022-02-28 | Viiv Healthcare Co | Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet |
-
2005
- 2005-04-20 US US11/110,589 patent/US7273859B2/en active Active
- 2005-04-22 CN CNA2005800236418A patent/CN1984917A/zh active Pending
- 2005-04-22 AU AU2005245789A patent/AU2005245789A1/en not_active Abandoned
- 2005-04-22 JP JP2007513169A patent/JP2007537251A/ja active Pending
- 2005-04-22 DK DK05738619T patent/DK1745052T3/da active
- 2005-04-22 CA CA002566755A patent/CA2566755A1/en not_active Abandoned
- 2005-04-22 SI SI200530425T patent/SI1745052T1/sl unknown
- 2005-04-22 MX MXPA06013023A patent/MXPA06013023A/es not_active Application Discontinuation
- 2005-04-22 ES ES05738619T patent/ES2310823T3/es active Active
- 2005-04-22 BR BRPI0511078-5A patent/BRPI0511078A/pt not_active IP Right Cessation
- 2005-04-22 EP EP05738619A patent/EP1745052B9/en active Active
- 2005-04-22 WO PCT/US2005/013911 patent/WO2005113562A1/en active Application Filing
- 2005-04-22 PT PT05738619T patent/PT1745052E/pt unknown
- 2005-04-22 DE DE602005009172T patent/DE602005009172D1/de not_active Expired - Fee Related
- 2005-04-22 NZ NZ550698A patent/NZ550698A/en unknown
- 2005-04-22 PL PL05738619T patent/PL1745052T3/pl unknown
- 2005-04-22 RU RU2006143683/04A patent/RU2006143683A/ru not_active Application Discontinuation
- 2005-04-22 AT AT05738619T patent/ATE405570T1/de not_active IP Right Cessation
- 2005-04-22 KR KR1020067023555A patent/KR20070014173A/ko not_active Application Discontinuation
- 2005-05-09 TW TW094114913A patent/TW200540173A/zh unknown
- 2005-05-11 PE PE2005000520A patent/PE20060238A1/es not_active Application Discontinuation
- 2005-05-11 AR ARP050101931A patent/AR049498A1/es not_active Application Discontinuation
- 2005-11-14 US US11/273,671 patent/US7419969B2/en active Active
-
2006
- 2006-11-03 ZA ZA200609181A patent/ZA200609181B/en unknown
- 2006-11-09 IL IL179161A patent/IL179161A0/en unknown
- 2006-11-27 NO NO20065443A patent/NO20065443L/no not_active Application Discontinuation
-
2008
- 2008-11-17 HR HR20080531T patent/HRP20080531T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050256109A1 (en) | 2005-11-17 |
| HRP20080531T3 (en) | 2009-03-31 |
| NZ550698A (en) | 2009-05-31 |
| ATE405570T1 (de) | 2008-09-15 |
| JP2007537251A (ja) | 2007-12-20 |
| AU2005245789A1 (en) | 2005-12-01 |
| DE602005009172D1 (de) | 2008-10-02 |
| IL179161A0 (en) | 2007-03-08 |
| RU2006143683A (ru) | 2008-06-20 |
| KR20070014173A (ko) | 2007-01-31 |
| EP1745052B1 (en) | 2008-08-20 |
| US20060106007A1 (en) | 2006-05-18 |
| EP1745052A1 (en) | 2007-01-24 |
| NO20065443L (no) | 2006-11-27 |
| US7273859B2 (en) | 2007-09-25 |
| PT1745052E (pt) | 2008-11-14 |
| AR049498A1 (es) | 2006-08-09 |
| WO2005113562A1 (en) | 2005-12-01 |
| US7419969B2 (en) | 2008-09-02 |
| BRPI0511078A (pt) | 2007-12-26 |
| TW200540173A (en) | 2005-12-16 |
| PE20060238A1 (es) | 2006-03-31 |
| MXPA06013023A (es) | 2006-12-20 |
| CA2566755A1 (en) | 2005-12-01 |
| ES2310823T3 (es) | 2009-01-16 |
| SI1745052T1 (sl) | 2009-04-30 |
| EP1745052B9 (en) | 2009-10-28 |
| ZA200609181B (en) | 2008-06-25 |
| PL1745052T3 (pl) | 2009-01-30 |
| CN1984917A (zh) | 2007-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1745052T3 (da) | HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelser | |
| NO20161521L (no) | Antivirale forbindelser | |
| DK1778702T3 (da) | Antivirale forbindelser | |
| ATE437875T1 (de) | Heterozyklische antivirale verbindungen | |
| ATE512960T1 (de) | Pyrimidinderivate | |
| ATE461202T1 (de) | Hiv-integrasehemmer | |
| DK1718608T3 (da) | Virale polymeraseinhibitorer | |
| DK2253614T3 (da) | IAP-inhibitorer | |
| DK1778718T3 (da) | Iap-inhibitorer | |
| DK1931350T3 (da) | Administration af inhibitorer af dipeptidylpeptidase | |
| DK1963369T3 (da) | Il-21-antagonister | |
| DE602005012636D1 (de) | Erung | |
| DK1763517T3 (da) | Pyrimidinderivater som 11beta-HSD1-inhibitorer | |
| ATE404546T1 (de) | Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen | |
| DK1713805T3 (da) | Kinaseinhibitorer | |
| ATE359743T1 (de) | Marknagel | |
| SE0400476L (sv) | Komponent | |
| ATE384719T1 (de) | Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen | |
| AT6947U3 (de) | Bob | |
| EE00444U1 (et) | Fosforiühend | |
| SE0402103D0 (sv) | Novel compounds | |
| AT7051U3 (de) | Bob | |
| ITLI20040005A1 (it) | Progetto autospesa | |
| DOP2004000959A (es) | Compuestos | |
| SE0402391D0 (sv) | Novelheterocyclic compounds |